D. Emans

Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation.

P. Lambin, W. Oyen, H. Aerts, 2012, Lung cancer.

The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer.

Jan-Jakob Sonke, Wouter van Elmpt, José Belderbos, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test

Paul Aljabar, Andre Dekker, Devis Peressutti, 2018, Medical physics.